Question
What is SCID? Describe its classification, diagnosis and symptoms.
Answer :
Word Count : 458
Severe Combined Immunodeficiency (SCID) is a group of rare, inherited disorders characterized by profound defects in both humoral and cell-mediated immunity. It results from impaired development and function of T lymphocytes along with variable defects in B lymphocytes and natural killer (NK) cells. Because of this combined immune deficiency, affected individuals are extremely susceptible to recurrent, severe, and often life-threatening infections from early infancy. SCID represents a medical emergency and is often fatal within the first _________ ____ ___ _______ __________.
___ __________ _____ __________ ________ __________ _________.
____ ____ ____ _________ ___ __________ ___ ________ _______ _________.
_____ __________ _________ _________ _________ ____ ________ _______.
______ ___ ________ _______ ____ _________ ______ ______.
_______ ______ _____ _________ ________.
____ ________ ______ ________ _________ _____ ____.
____ _____ ______ ______ ____ ________ _____ ______ _________.
_________ ________ ______ ___ _______ __________ ____ _______ _________ _____ ____.
_______ _________ _______ _______ ________ _______ ________ _______ ______.
________ ___ _____ ______ ____ _______ _________ _______ _____ __________ __________ _____.
_______ ____ _________ _______ ________ _______ _____ ____.
________ ________ ___ ____ ___ ______ ________ ____.
______ ____ __________ _______ ___ _______ _______ _______ ____ __________ ________.
_________ ______ ___ ____ _______ ______ _______ ____ _____ ________.
_______ __________ ________ ______ ___ _____ _____ _____.
_____ _______ ________ ________ _________ _____ __________.
________ ________ __________ _______ ___ _____ ______.
__________ ________ ___ __________ _________ _______ _________ __________ ____ _________ ________.
______ _____ ___ __________ ____ __________ ______ ___ ________ _________ ________.
___ _______ _______ ________ ______ ___ _______ __________.
_______ _____ _____ ________ _________ _____ ______ ________ ______ ________ _________.
______ _______ ____ _______ _______ ______ _______.
_________ ________ ___ __________ ___ __________ ________ _____ ________.
_________ ______ ____ ___ _________ ___ ____.
__________ __________ ______ __________ ___ _____ _______ ___ ______ _______.
_________ ____ _________ ___ ________ ______ ____ ______.
_______ ____ ______ _____ ______ ___ ______ ___ _________ ________ _____ ___.
___ __________ ________ __________ _______ ______ ____.
______ _______ ___ _____ _____ __________ _________ _____ ____ ___.
_________ __________ __________ _____ ____ _____.
_____ ____ _____ __________ ___ _____ ______.
______ ________ ________ ___ ____.
________ _________ ___ ______ ________ ______ _____ ________ __________ _____ ________.
___ _____ ________ ___ ___ _________ _________ ___ _____ _________ _____ ______.
_______ _________ __________ ________ __________ _______ __________.
__________ __________ _____ _____ _______ _____.
__________ ______ ____ __________ ____ ______.
_____ ___ ____ _________ __________ ________ ______ ____ ___ _____.
_____ _________ _________ _________ ___ _______ _________.
__________ _____ ________ _____ _________ _____ _________ ______.
__________ ___ _________ ________ __________ _______ ______ ___ __________ _____ _________.
________ ___ ___ ____ _________ _________ __________ ____ _______ _______ ____.
____ ___ _________ _____ ____ ____ ________ __________ ___.
____ ________ _______ _________ ___.
Get Full Answer on WhatsApp
Severe Combined Immunodeficiency (SCID) is a group of rare, inherited disorders characterized by profound defects in both humoral and cell-mediated immunity. It results from impaired development and function of T lymphocytes along with variable defects in B lymphocytes and natural killer (NK) cells. Because of this combined immune deficiency, affected individuals are extremely susceptible to recurrent, severe, and often life-threatening infections from early infancy. SCID represents a medical emergency and is often fatal within the first _________ ____ ___ _______ __________.
___ __________ _____ __________ ________ __________ _________.
____ ____ ____ _________ ___ __________ ___ ________ _______ _________.
_____ __________ _________ _________ _________ ____ ________ _______.
______ ___ ________ _______ ____ _________ ______ ______.
_______ ______ _____ _________ ________.
____ ________ ______ ________ _________ _____ ____.
____ _____ ______ ______ ____ ________ _____ ______ _________.
_________ ________ ______ ___ _______ __________ ____ _______ _________ _____ ____.
_______ _________ _______ _______ ________ _______ ________ _______ ______.
________ ___ _____ ______ ____ _______ _________ _______ _____ __________ __________ _____.
_______ ____ _________ _______ ________ _______ _____ ____.
________ ________ ___ ____ ___ ______ ________ ____.
______ ____ __________ _______ ___ _______ _______ _______ ____ __________ ________.
_________ ______ ___ ____ _______ ______ _______ ____ _____ ________.
_______ __________ ________ ______ ___ _____ _____ _____.
_____ _______ ________ ________ _________ _____ __________.
________ ________ __________ _______ ___ _____ ______.
__________ ________ ___ __________ _________ _______ _________ __________ ____ _________ ________.
______ _____ ___ __________ ____ __________ ______ ___ ________ _________ ________.
___ _______ _______ ________ ______ ___ _______ __________.
_______ _____ _____ ________ _________ _____ ______ ________ ______ ________ _________.
______ _______ ____ _______ _______ ______ _______.
_________ ________ ___ __________ ___ __________ ________ _____ ________.
_________ ______ ____ ___ _________ ___ ____.
__________ __________ ______ __________ ___ _____ _______ ___ ______ _______.
_________ ____ _________ ___ ________ ______ ____ ______.
_______ ____ ______ _____ ______ ___ ______ ___ _________ ________ _____ ___.
___ __________ ________ __________ _______ ______ ____.
______ _______ ___ _____ _____ __________ _________ _____ ____ ___.
_________ __________ __________ _____ ____ _____.
_____ ____ _____ __________ ___ _____ ______.
______ ________ ________ ___ ____.
________ _________ ___ ______ ________ ______ _____ ________ __________ _____ ________.
___ _____ ________ ___ ___ _________ _________ ___ _____ _________ _____ ______.
_______ _________ __________ ________ __________ _______ __________.
__________ __________ _____ _____ _______ _____.
__________ ______ ____ __________ ____ ______.
_____ ___ ____ _________ __________ ________ ______ ____ ___ _____.
_____ _________ _________ _________ ___ _______ _________.
__________ _____ ________ _____ _________ _____ _________ ______.
__________ ___ _________ ________ __________ _______ ______ ___ __________ _____ _________.
________ ___ ___ ____ _________ _________ __________ ____ _______ _______ ____.
____ ___ _________ _____ ____ ____ ________ __________ ___.
____ ________ _______ _________ ___.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★